WNK3 abrogates the NEDD4-2-mediated inhibition of the renal Na+:Cl- Cotransporter.

WNK3 abrogates the NEDD4-2-mediated inhibition of the renal Na+:Cl- Cotransporter. Am J Physiol Renal Physiol. 2014 Jun 11; Authors: Lagnaz D, Arroyo JP, Chavez-Canales M, Vazquez N, Rizzo F, Spirli A, Debonneville A, Staub O, Gamba G Abstract The serine/threonine kinase WNK3 and the ubiquitin-protein ligase NEDD4-2 are key regulators of the thiazide-sensitive Na(+):Cl- cotransporter (NCC), WNK3 as an activator and NEDD4-2 as an inhibitor. Nedd4-2 was identified as an interacting partner of WNK3 through a GST pulldown assay using the N-terminal domain of WNK3, combined with LC-MS/MS analysis. This was validated by co-immunoprecipitation of WNK3 and NEDD4-2 expressed in HEK293 cells. Our data also revealed that the interaction between Nedd4-2 and WNK3 does not involve the PY-like motif found in WNK3. The level of WNK3 ubiquitylation did not change, when NEDD4-2 was expressed in HEK293 cells. Moreover, in contrast to SGK1, WNK3 did not phosphorylate NEDD4-2 on S222 or S328. Co-immunoprecipitation assays showed that WNK3 does not regulate the interaction between NCC and NEDD4-2. Interestingly, in Xenopus laevis oocytes, WNK3 was able to recover the SGK1-resistant NEDD4-2 S222AS328A-mediated inhibition of NCC and further activate NCC. Furthermore, elimination of the SPAK binding site in the kinase domain of WNK3 (WNK3-F242A, which lacks the capacity to bind the serine/threonine kinase SPAK) prevented the WNK3 NCC activating effect, but n...
Source: Am J Physiol Renal P... - Category: Urology & Nephrology Authors: Tags: Am J Physiol Renal Physiol Source Type: research